ATG13 — Autophagy Related 13

ATG13 — Autophagy Related 13

Introduction

ATG13 — Autophagy Related 13

Introduction

ATG13 (Autophagy Related 13) is a critical gene encoding a key regulator of the autophagy initiation machinery in eukaryotic cells. The ATG13 protein serves as a central scaffold within the ULK1 (Unc-51 Like Autophagy Activating Kinase 1) complex, coordinating the assembly and activation of the autophagosome nucleation machinery that is essential for both bulk autophagy and selective forms of autophagic degradation. In neurons—post-mitotic cells that cannot rely on cell division to eliminate damaged components—ATG13-dependent autophagy plays a particularly crucial role in maintaining synaptic homeostasis, clearing pathological protein aggregates, and preserving mitochondrial quality control through mitophagy["@mizushima2007"][@komatsu2005].

The ATG13 gene is located on chromosome 11p11.2 and encodes a protein of approximately 559 amino acids with a molecular weight of approximately 60 kDa. The protein contains multiple domains that facilitate its role as a molecular scaffold, including an LC3-interacting region (LIR) that enables binding to lipidated LC3/GABARAP proteins on the forming autophagosome membrane. ATG13 is highly conserved across eukaryotes, reflecting its fundamental role in autophagy regulation["@kritschi2016"][@johansen2009].

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Autophagy Related 13</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>ATG13</td></tr>
<tr><td><strong>Full Name</strong></td><td>Autophagy Related 13</td></tr>
<tr><td><strong>Chromosome</strong></td><td>11p11.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[9456](https://www.ncbi.nlm.nih.gov/gene/9456)</td></tr>
<tr><td><strong>OMIM</strong></td><td>614608</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000152256</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9UQL6](https://www.uniprot.org/uniprot/Q9UQL6)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Parkinson's Disease](/diseases/parkinsons-disease), [Huntington's Disease](/diseases/huntingtons-disease), [ALS](/diseases/als), [Alzheimer's Disease](/diseases/alzheimers-disease)</td></tr>
</table>
</div>

Molecular Function

The ULK1 Complex Architecture

ATG13 serves as the core scaffold protein within the ULK1 complex, a multiprotein assembly that functions as the master regulator of autophagosome formation. The canonical ULK1 complex consists of four core components:

The ULK1 complex functions as a signal transduction hub that integrates nutritional, energetic, and stress signals to coordinate autophagosome formation. Under nutrient-rich conditions, mTORC1 (mammalian Target of Rapamycin Complex 1) phosphorylates ATG13 and ULK1, maintaining the complex in an inactive state. Upon nutrient withdrawal or cellular stress, mTORC1 activity is inhibited, allowing dephosphorylation and activation of the ULK1 complex[@itakura2012][@liu2022].

ATG13 Structural Features

The ATG13 protein contains several functional domains essential for its role in autophagy regulation:

• Hor domain (HR): Located at the N-terminus, mediates protein-protein interactions
• LIR (LC3-interacting region): At the C-terminus, enables binding to LC3/GABARAP family proteins
• UBAN-like motif: Facilitates interaction with specific autophagy receptors
• Phosphorylation sites: Multiple serine/threonine residues that regulate complex activity

Autophagy Initiation Mechanism

Upon autophagy induction, the activated ULK1 complex translocates to nascent autophagosome formation sites, where it initiates a phosphorylation cascade:

This hierarchical assembly ensures precise spatiotemporal control of autophagosome biogenesis[@nishimura2022][@ruiz2021].

Role in Neurodegenerative Diseases

Parkinson's Disease

In [Parkinson's Disease](/diseases/parkinsons-disease), ATG13-dependent autophagy is critical for clearing [α-synuclein](/proteins/alpha-synuclein) aggregates that characterize the disease. PINK1-PARKIN-mediated mitophagy, a specialized form of selective autophagy, relies on ATG13 function to eliminate damaged mitochondria. Studies have shown that:

• ATG13 expression is altered in PD patient brains, with reduced levels in the substantia nigra[@zhang2023]
• Loss of ATG13 function leads to accumulation of dysfunctional mitochondria and increased [α-synuclein](/proteins/alpha-synuclein) aggregation
• ATG13 deficiency exacerbates dopaminergic neuron loss in animal models
• Therapeutic strategies targeting ATG13-dependent mitophagy show promise for PD treatment

Alzheimer's Disease

In [Alzheimer's Disease](/diseases/alzheimers-disease), ATG13 plays a complex role in the clearance of amyloid-β plaques and tau tangles. Autophagy flux is impaired in AD neurons, contributing to the accumulation of toxic protein aggregates:

• ATG13-mediated autophagy contributes to amyloid-β degradation through the autophagy-lysosome pathway
• Tau pathology disrupts autophagy machinery, including the ULK1 complex
• Restoring ATG13 function enhances clearance of hyperphosphorylated tau
• The autophagy-lysosome pathway in AD neurons shows reduced ATG13 phosphorylation and impaired activation

Amyotrophic Lateral Sclerosis (ALS)

In [ALS](/diseases/als), ATG13 dysfunction contributes to the pathogenesis of TDP-43 proteinopathy, a hallmark of most ALS cases:

• TDP-43 aggregates sequester autophagy proteins including ATG13
• ATG13 levels are reduced in ALS patient spinal cord tissue
• Loss of ATG13 function impairs clearance of dysfunctional proteins and organelles
• Mutations in autophagy genes (including OPTN, TBK1, p62) interact with ATG13 pathway

Huntington's Disease

In [Huntington's Disease](/diseases/huntingtons-disease), ATG13 is essential for clearing mutant huntingtin protein aggregates:

• The ULK1-ATG13 complex is required for selective autophagy of mutant huntingtin
• ATG13 deficiency leads to accumulation of insoluble huntingtin aggregates
• Autophagy induction through mTOR inhibition reduces huntingtin toxicity
• ATG13 function is modulated by the huntingtin protein itself

Expression Pattern

Brain Expression

ATG13 is widely expressed in the central nervous system, with particularly high levels in:

• Cerebral cortex: Pyramidal neurons and interneurons
• Hippocampus: CA1-CA3 pyramidal cells and dentate gyrus granule cells
• Cerebellum: Purkinje cells and granule cells
• Substantia nigra: Dopaminergic neurons
• Spinal cord: Motor neurons and interneurons

Regulation by Cellular Stress

ATG13 expression and function are regulated by multiple cellular stress pathways:

• Nutrient deprivation: Upregulates ATG13 expression and promotes complex activation
• Oxidative stress: Activates ULK1-ATG13 complex through AMPK
• ER stress: ATG13 contributes to ER-phagy (reticulophagy) initiation
• Mitochondrial damage: Facilitates mitophagy induction through PINK1-PARKIN pathway

Therapeutic Implications

Pharmacological Targeting

The ATG13-ULK1 axis represents a druggable target for neurodegenerative diseases:

| Compound | Mechanism | Clinical Status |
|----------|-----------|-----------------|
| Rapamycin | mTOR inhibitor, induces autophagy | FDA-approved for transplant, trials for PD |
| Torin 1 | mTORC1/2 inhibitor | Preclinical |
| ULK1 activators | Direct ULK1 activation | Discovery phase |
| Autophagy enhancers | Trehalose, spermidine | Clinical trials for AD/PD |

Gene Therapy Approaches

• AAV-mediated ULK1/ATG13 overexpression
• Small molecule activators of the ULK1 complex
• siRNA approaches to modulate ATG13 expression
• CRISPR-based gene editing to enhance autophagy

Allen Brain Atlas Data

ATG13 shows widespread expression across brain regions with particularly high expression in the cerebral cortex, hippocampus, and cerebellum based on Allen Human Brain Atlas data. In neuronal populations, ATG13 expression is elevated in Purkinje cells of the cerebellum and pyramidal neurons of the hippocampus, consistent with its critical role in autophagy within long-lived neurons. Single-cell expression data from the Allen Brain Cell Atlas indicates ATG13 is expressed in multiple neuronal and glial cell types, with particularly high expression in excitatory neurons and astrocytes. The gene's expression pattern supports its importance in neuronal autophagy and protein aggregate clearance mechanisms relevant to neurodegenerative diseases.

Resources:

• [Allen Brain Atlas Gene Expression](https://human.brain-map.org/gene/show?gene_id=ENSG00000152256)
• [Allen Brain Cell Atlas - ATG13](https://celltype.brain-science.org/)

Key Research Findings

1. ATG13 in Autophagosome Formation

The foundational discovery by Mizushima and colleagues established ATG13 as an essential component of the autophagy machinery. Their studies demonstrated that ATG13 is required for autophagosome formation in mammalian cells and that it functions as part of the ULK1 complex to coordinate the recruitment of downstream autophagy proteins[@mizushima2007].

2. ATG13 in Aggregate Clearance

Komatsu et al. demonstrated that ATG13 and p62/SQSTM1 cooperate in selective autophagy of ubiquitinated protein aggregates. This work established the framework for understanding how ATG13-dependent autophagy contributes to clearance of pathological protein aggregates in neurodegenerative diseases[@komatsu2005].

3. ATG13 Structure-Function Studies

Itakura and colleagues provided detailed mechanistic insights into the ULK1-ATG13-FIP200-ATG101 complex, demonstrating how ATG13 serves as a molecular scaffold to integrate upstream signals with downstream autophagy effectors[@itakura2012].

4. Therapeutic Potential in PD

Zhang et al. demonstrated that ATG13-dependent mitophagy is impaired in Parkinson's disease models and that pharmacological activation of this pathway provides neuroprotection. This work supports ATG13 as a therapeutic target for PD[@zhang2023].

See Also

• [Autophagy](/mechanisms/autophagy)
• [ULK1 Complex](/mechanisms/ulk1-complex)
• [Mitophagy](/mechanisms/mitophagy)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [ALS](/diseases/als)
• [Huntington's Disease](/diseases/huntingtons-disease)
• [ULK1 Gene](/genes/ulk1)
• [FIP200 Gene](/genes/fip200)

External Links

• [NCBI Gene - ATG13](https://www.ncbi.nlm.nih.gov/gene/9456)
• [UniProt - ATG13](https://www.uniprot.org/uniprot/Q9UQL6)
• [Ensembl - ATG13](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000152256)
• [GeneCards - ATG13](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ATG13)
• [HGNC - ATG13](https://www.genenames.org/data/hgnc_data.php?hgnc_id=24117)

Pathway Diagram

The following diagram shows the key molecular relationships involving ATG13 — Autophagy Related 13 discovered through SciDEX knowledge graph analysis: